Rieter (RIEN) investor relations material

Executive summary

• Order intake for the first nine months of 2025 was CHF 559.3 million, down 11% year-over-year, but up 11% excluding a large prior-year Chinese order; sales fell 22% to CHF 457.7 million, reflecting challenging market conditions and lower volumes in the Machines & Systems division.

• The Barmag/Barmark acquisition is progressing as planned, with financing secured through a record equity raise and CHF 750 million in syndicated credit facilities; regulatory approvals are expected by year-end.

• Significant cost reduction and performance improvement measures have been implemented, including organizational simplification and supply chain optimization.

• Order backlog as of September 30, 2025, was CHF 590 million, down from CHF 690 million a year earlier.

• Strategic progress includes advances in automation and digitization, with new solutions to be presented at ITMA Asia and a fully automated spinning mill planned for ITMA 2027.

Financial highlights

• Order intake for the first nine months was CHF 559.3 million, down 11% year-over-year; adjusted for major 2024 orders, intake increased 11%.

• Sales for the first nine months were CHF 457.7 million, a 22% decrease from CHF 584.3 million in 2024, with negative FX translation impact of CHF 11.6 million.

• Machines & Systems order intake down 17% to CHF 287.1 million, sales down 27% to CHF 191.9 million; Components order intake down 13% to CHF 142.6 million, sales down 16% to CHF 154.6 million; After Sales order intake up 9% to CHF 129.6 million, sales down 18% to CHF 111.2 million.

• Regional sales grew in China (+13%), North and South America (+16%), and Europe (+11%), but declined sharply in Türkiye (-72%), Africa (-75%), and other Asian countries (-30%).

• Net financial expenses for 2025, including acquisition-related costs, are expected to be around CHF 20 million.

Outlook and guidance

• Full-year 2025 sales guidance lowered to around CHF 700 million (previously CHF 750–800 million), excluding Barmag/Barmark.

• Operating EBIT margin expected at the lower end of 0–4%, excluding restructuring and acquisition costs.

• Transaction and restructuring costs will impact EBIT by approximately CHF 15 million; net result for 2025 is expected to be negative due to extraordinary costs.

• Conservative approach for 2026, with continued cost measures and performance programs; some hope for improvement but planning remains cautious.